Population Pharmacokinetics-Pharmacodynamics and Exposure-Response of Ropeginterferon Alfa-2b in Chinese and Japanese Patients With Polycythemia Vera. [PDF]
Qin A+18 more
europepmc +1 more source
Masked polycythemia Vera (mPV): Results of an international study
semanticscholar +1 more source
Authors response comments on: Evaluating the impact of polycythemia vera on retinal and optic nerve head microvascularity: An OCTA study. [PDF]
Cicek MF+4 more
europepmc +1 more source
High pulmonary hypertension risk by echocardiogram shortens survival in polycythemia vera. [PDF]
Gazda AJ+6 more
europepmc +1 more source
A pharmacovigilance study of adverse events associated with polycythemia vera treatments using the FDA Adverse Event Reporting System (FAERS) database. [PDF]
Reeves BN+9 more
europepmc +1 more source
What is the optimal strategy for secondary prevention after venous thromboembolism in polycythemia vera? [PDF]
Ajufo H, Vaughn J.
europepmc +1 more source
Low frequency of JAK2 exon 12 mutations in classic and atypical CMPDs [PDF]
Aranaz-Oroz, P. (Paula)+7 more
core +1 more source
Impact of ELN clinical signs and symptoms on the thrombotic risk in polycythemia vera patients treated with front-line hydroxyurea. [PDF]
Palandri F+17 more
europepmc +1 more source